Companies and AI developments
Updates
Daily market commentary, company analyses, investment stories and AI news. Price-only updates require a cumulative move of greater than 15% from the last published assessment. Newest first.
Daily commentary PPI Broadens Inflation Pressure as the Market Distinguishes Between AI Demand and Debt Read article →
Added the company analysis in Czech and English.
Added the company analysis in Czech and English.
Daily commentary Hot CPI Hits AI Stocks, Energy Keeps Squeezing Consumers Read article →
SoFi — added the Orbi/Mastercard partnership in Mexico, the actual June SoFiUSD balance and the approaching convertible-note maturity. The partnership's financial contribution is not yet quantified; credit quality and capital remain the main test.
Microsoft — corrected segments and comparable KPI definitions using the September recast; this is not a decline in demand. Maia was added, but promised savings are not yet included in EPS or cash-flow estimates.
Zeta — added AthenaOS, the Senso/Digital Audience acquisition agreements and the unresolved discrepancy between NRR sources. Monetization and transaction financing remain unestablished; model assumptions are not raised.
Q3 2026 earnings UnitedHealth — Q3 strengthened the recovery thesis: adjusted EPS of USD 4.69 and full-year guidance of at least USD 20.50. Business strength of 7.2/10 and attractiveness of 6.0/10 are unchanged at the October 13 pre-market price of USD 384.19; reserves and repricing remain the main risks.
Daily commentary Market Awaits CPI: Oil Above $106 and Yields Keep Valuations Under Pressure Read article →
PRU — business strength 6.4/10 and price attractiveness 6.0/10 unchanged; assessment updated to October 13 at the October 12 close of 113.39 USD under methodology 1.1. Added specific POJ remediation plans from the October 8 announcement; reform effectiveness remains unproven.
Daily commentary Expensive oil and narrow gains raise the bar for earnings Read article →
Added the company analysis in Czech and English.
Added the company analysis in Czech and English.
Daily commentary Oil eases ahead of a week of inflation data and corporate earnings Read article →
Initial business strength 6.8/10, price attractiveness 7/10 at 63.37 USD. The dividend thesis remains conditional on AFFO per share growth and financing; the past dividend cut still limits management confidence.
The existing recovery thesis is formalized as strength 7.2/10 and attractiveness 6/10 at 379.30 USD. Dividends, dilution and discounted-value checks are added; durable margin recovery remains decisive.
FSA action extends POJ restrictions through January 31, 2027 and affects part of Gibraltar; the thesis remains conditional on governance repair and cash transfers. New strength 6.4/10 and attractiveness 6/10 at 113.09 USD.
Initial scores: business strength 7.6/10 and price attractiveness 7/10 at 54.18 USD. Long leases and dividend coverage support the thesis; per-share growth and capital costs remain the main test.
Initial scores: strength 7.2/10, attractiveness 6/10 at 16.51 USD. The three-year model counts only the base dividend; the NAV premium and credit resilience limit the safety margin.
Initial scores: strength 7.0/10, attractiveness 7/10 at 38.28 USD. The base multiple is reduced to 10.5× and the adverse case strengthened with lower AFFO and dilution; Bally’s remains the main risk.